The presence of tissue factor is essential for factor VIIa (FVIIa) to reach its full catalytic potential. The previous work in this laboratory demonstrated that substitution of the EGF1 domain of factor VIIa with that of factor IX (FVII (IXegf1) a) results in a substantial decrease in TF-binding af®-nity and catalytic activity. Supporting simulations of the solution structures of Ca 2 -bound factor VIIa and FVII (IXegf1) a with tissue factor are provided. Mutants are generated, based on the simulation model, to study the effect of EGF1 substitution on catalytic activity. The simulations show larger Gla-EGF1 and EGF1-EGF2 inter-domain motions for FVII (IXegf1) a than for factor VIIa. The catalytic domain of the chimeric factor VIIa has been disturbed and several surface loops in the catalytic domain of FVII (IXegf1) (IXegf1) a, near the N terminus insertion site of the catalytic domain, shifts relative to factor VIIa, resulting in a slight alteration of the active site. The results suggest that these four loops mediate the effect of the EGF1 domain substitution on the S1 site and catalytic residues. To test the model, we prepared mutations of these surface loops, including four FVII mutants, D186A, K188A, L144A and R147A, a FVII mutant with multiple mutations (MM3: L144A R147A D186A) and a FVII mutant with Loop 170s partially deleted, Loop 170s del . The catalytic activities towards a small peptidyl substrate decreased 2.4, 4.5 and 9-fold for Loop 170s del a (a, activated), L144Aa and D186Aa, respectively, while MM3a lost almost all catalytic activity. The combined results of the simulations and mutants provide insight into the mechanism by which tissue factor enhances factor VIIa catalytic activity.
Introduction
Blood coagulation factor VIIa (FVIIa) is a trypsin-like plasma serine protease. FVIIa in its cataly-tic domains has strong primary sequence identity and tertiary structure similarity with trypsin and chymotrypsin. These enzymes (FVIIa is an example, Figure 1 ) share common catalytic triad residues, H57, D102 and S195 (the catalytic domain residues being represented with chymotrypsin numbering system, except where indicated), and are largely characterized by their S1-binding sites. FVIIa and trypsin bear an aspartic acid (D189) at the bottom of their S1 pockets, which accounts for the substrate speci®city for the positively charged residues, arginine or lysine. The residue at the bottom of S1 site, however, is not suf®cient for determination of substrate speci®city. Two loops on the surface of trypsin, Loop 1 (185-188) and Loop 2 (221A-225), in concert with Loop 140s (142) (143) (144) (145) (146) (147) (148) (149) (150) (151) (152) and the N terminus insertion (16) (17) (18) (19) are collectively called``the activation domain''. 1, 2, 3 The active domain is stabilized upon conversion of the zymogen to trypsin 2 and probably also rearranges upon TF binding to FVIIa. 3 These loops and Y172, which is located on Loop 170s (170-182) and is near Loop 2 and the catalytic cleft, have been shown to play important roles in the determination of substrate speci®city. 4 FVIIa is a multi-domain molecule, 5 including a proteolytic domain at the C terminus (residues 16 to 257), and a g-carboxyglutamic-acid-rich domain (Gla) at the amino terminus. Two epidermal growth-factor-like domains, EGF1 and EGF2, connect the Gla and catalytic domains. The N terminus three domains de®ne the light chain. Once activated, the zymogen FVII is cleaved at the R152L-I16 (L, the light chain) peptide bond into a light chain and a heavy chain (catalytic domain), which remain connected by a disul®de bond. The amino terminus residue I16 of the heavy chain inserts into a groove to form two H-bonds with residue D194 (Figure 1 ). D194 is adjacent to the catalytic residue S195 and to G193. The amide nitrogen atoms of the latter two residues bind the negatively charged oxygen of the carbonyl cleavage position to stabilize the tetrahedral intermediate. 6, 7 In addition to the necessary conformational changes that occur in the regions near the active site, FVIIa must bind its cofactor, tissue factor (TF), in the presence of membrane and calcium ions to exhibit full catalytic activity. TF consists of three sections, an extracellular fragment (1-219), a transmembrane region (220-242) and a small cytoplasmic domain (243-263) 8, 9, 10 . Extracellular TF is composed of a N terminus (1-103) and C terminus (104-210) domain. 11 X-ray crystallography 5 shows that the FVIIa-TF complex interaction involves all FVIIa domains. The Gla domain, which is pre- Figure 1 . Simpli®ed ribbon diagram of the catalytic domain of FVIIa. 5 The catalytic triad residues, H57, D102 and S195 are represented by the ®lled spheres (in red). The inhibitor, DFFR chloromethyl ketone (in green), occupies the active site, with its backbone parallel to the catalytic cleft and its arginine side-chain stretching into the S1 substrate binding site, which is partially composed of Loop 1 (185-188, yellow) and Loop 2 (221A-225, white). The arginine guanidinum group forms a salt bridge with D189 (in yellow) at the bottom of S1. The amino terminus of the catalytic domain (in pink) inserts into a groove, where the main-chain atom N of I16 forms a salt bridge with D194 (in pink). Loop 140s is located at the upper right in orange. The a-helix 164-169 and Loop 170s (170-182) are to the left (in cyan). The thin lines in green and yellow (lower left corner) represent TF.
sumed to contact a membrane surface, is in contact with the extracellular C terminus of TF. The EGF1 domain forms an interface with the central section of TF and the third interface involves the catalytic domain, EGF2 and the N terminus of TF. The catalytic domain-TF interface consists mainly of two small a-helices, a-129B-129G and a-164-167 of FVIIa and the N terminus domain of TF. FVIIa Residues F129F, R134, Q166 and D167 form H-bonds with TF residues. The M164 side-chain inserts into a hydrophobic pocket on TF. 5 Substitution of R134 or M164 with alanine causes a defect in FX activation 12 and in chromogenic substrate hydrolysis and diminishes co-factor enhancement of small-substrate hydrolysis. 13 M164 has been reported 14 to transmit the allosteric changes to the active site caused by TF-binding and conversely to mediate increased TF-binding af®nity resulted from small peptide inhibitor binding to the active site. The a-helix 164-169 is found distorted, 15 and Loop 170s, which follows the a-helix 164-167 and is located between the catalytic domain-TF interface and the active site, shows high¯exibility in the inhibitor-bound TF-free state of FVIIa. 15, 16 The EGF1 domain of FVIIa provides most of the binding interaction with TF. The high-af®nity calcium-binding site located at the N terminus of the EGF1 domain has been implicated in cofactor activity of TF. 17 Mutation of TF residues contacting the EGF1 domain affects catalytic activity. 18, 19, 20 Previously we 21, 22 demonstrated that substitution of the FVII EGF1 domain with that of FIX (FVII (IXegf1) a) greatly reduced TF-binding af®nity. Catalytic ef®ciencies towards a synthetic substrate and FX were also affected 21 by the chimeric substitution in the presence of TF. We subsequently suggested that the allosteric effect of substitution of the EGF1 domain on the enzyme's catalytic activity is transmitted through the misalignment of the catalytic domain-TF interface to the active site and/or a macromolecular substrate-binding site. 21 It is interesting that an allosteric linkage between the EGF1 domain and the active site has also been observed in free FVIIa using a conformation-sensitive FVII-EGF1-speci®c antibody. 23 To study the effect of EGF1 substitution on the catalytic activity of FVIIa, we have performed molecular dynamics (MD) simulations of both wild-type FVIIa and the chimeric FVIIa in the presence of TF using the Amber force ®eld. 24 The simulations were performed in solution using the FVIIa-TF complex coordinates 5 to provide the initial system. The simulation results were then tested experimentally using in vitro mutagenesis. The experimental evidence supports our hypothesis, derived from the simulation, that four loops, Loop 170s, Loop 1, Loop 2 and Loop 140s, on the surface of the catalytic domain mediate the effect of the EGF1 domain substitution on catalytic activity of FVIIa, suggesting the manner by which TF enhances FVIIa's enzymatic activity.
Results

RMSD analysis of the simulation
It is important to establish that the simulation system is equilibrated before the simulation structure is analyzed. Evaluating RMSDs has been demonstrated to be an appropriate procedure for monitoring equilibration of the simulation structure. 25 A RMSD analysis is also valuable for observing individual domain stability and interdomain motion in a multiple-domain macromolecule. The RMSD pro®le of the wild-type FVIIa-TF simulation for 510 ps is depicted in Figure 2 . We used the entire complex FVIIa-TF, FVIIa, or TF, and individual domains (Gla, EGF1, EGF2, the catalytic domain) of the initial energy minimized con®guration of FVIIa-TF complex as reference coordinates, respectively, to calculate RMSD values of backbone carbon atoms at half picosecond intervals. In panel a, the RMSD baselines¯uctuated around 1.25 A Ê for TF, 1.4 A Ê for FVIIa and 1.5 A Ê for FVIIa-TF, indicating equilibration of the simulation system in solution. The¯uctuations of the Gla and the EGF1 RMSDs with respect to their initial structures are approximately 0.6 A Ê (0.59(AE 0.07) A Ê for EGF1; (b)). The catalytic and the EGF2 domains show equilibration as well (Figure 2(b) ). FVIIa alone, or in complex with TF, shows somewhat larger RMSDs relative to each individual domain, suggesting that limited inter-domain motion occurred during simulation. We employed Gla-EGF1, EGF1-EGF2, and EGF2-catalytic domain coordinates of the starting structure as references to examine domain-domain motions in FVIIa. Figure 2 (c) demonstrates that limited domaindomain motions occurred between EGF1 and EGF2 and between Gla and EGF1. For the chimeric FVII (IXegf1) a-TF, the simulation RMSDs of more than 800 ps are presented in Figure 3 . All subdomains, except EGF1, shows RMSD¯uctuations (Figure 3(b) ) similar to the wild-type. The EGF1 domain of FVII (IXegf1) a has an increased RMSD (0.88(AE0.07) A Ê ), compared to the EGF1 domain of FVIIa (0.59(AE0.07) A Ê ). The p-value is less than 0.001. Likewise FVII (IXegf1) a and FVII (IXegf1) a-TF display larger RMSD pro®les (panel a) than those of wild-type FVIIa-TF. TF also shows similar, although smaller,¯uctuations. Thus increased domain motions are presented due to the EGF 1 domain substitution. Most of the domain-domain motion occurs between EGF1 and EGF2, and between the Gla and EGF1 domains (Figure 3(c) ).
B-factor analyses
The B-factor is an experimental measure of the thermal harmonic motion of the atoms. The larger the value, the less localized the atom. The (pseudo) B-factors for simulation can be computed from the¯uctuations of atoms about their mean positions. We employed the last 100 ps trajectories to calculate B-factors. Figure 4 represents the differ-ences between FVIIa-TF and FVII (IXegf1) a-TF B-factor pro®les. The initial-time structure of each domain was used as the reference in the B-factor calculation so as to eliminate domain-domain motion. Several peaks in the B-factor versus time plots are observed. The FVII residues in the regions of the peaks are located in loops and are not in contact with TF. In general, the B-factors of the residues in these loops are less than 40. The B-factors for residues in the catalytic domain of FVIIa are between 20 and 40. TF residues 78t-80t (t:TF) and 163t-165t have signi®cant thermal¯uctuation due to their fragment-terminal location. In addition, the B-factor pro®le of the FVIIa-TF simulation is similar in pattern to those of several X-ray crystallography studies (data not shown).
The B-factor pro®le of FVII IXegf1 a-TF (Figure 4 ) is similar to that of FVIIa-TF. In the catalytic domain of the chimera (Figure 4(a) ), however, B-factors greater than the wild-type FVIIa occur for residues Figure 2 . Root-mean-square deviations (RMDS) of the backbone carbon atoms of FVIIa-TF. RMDSs were calculated every 0.5 ps by superimposing the simulation structures. The structure at 0 ps of the plot has undergone a slow heat-up and a cool-down procedure followed by solution simulation for 50 ps of the starting structure. RMDSs are calculated using (a) the entire molecule (FVIIa-TF, FVIIa or TF) as reference; (b) individual domains as reference, and (c) adjacent domains as reference so as to uncover inter-domain motions. 170C-175 (see Table 1 for the full-length numbering as used in Figure 4 
Local conformational changes
In general, FVIIa-TF and FVII (IXegf1) a-TF show very similar SAA (solvent accessible areas) pro®les (not shown). Only a few small changes of SAA are observed for residues 170 to 170G of the catalytic domain. The EGF1 substitution caused SAA changes at positions 64, 69, 79 and 88 of the light chain. Residue 64, which coordinates the calcium ion located at the interface between the Gla and EGF1 domains and is also involved in TF binding, 5 is more exposed in FVII (IXegf1) a than in FVIIa (50.8 A Ê 2 versus 5.6 A Ê 2 , respectively). The side-chain of I69 was almost completely buried in FVIIa, but E69 (40 A Ê 2 ) is partially exposed in the chimera. Residue Q88 is located at the junction between EGF1 and EGF2. The aliphatic part of the Q88 side-chain, in concert with N93, V92, F50t and Y51t, also de®nes a hydrophobic interaction between EGF2 and TF. The changes in residues 64, 69, 79 and 88 could result in inter-domain motions and/or reduction of TF-binding af®nity. Signi®cant SAA changes for TF are found at residues 50 and 91. F50t is involved in a hydrophobic interaction with the side-chain of Q88. E91t is the N terminus residue of the second fragment of TF and is involved in H-bonding to E178 and R230 of FVIIa. Altering the E91t side-chain interactions (SAA 9.8 A Ê 2 for the chimera versus 41 A Ê 2 for the wild-type) could result in important changes for the interaction between the catalytic domain of FVIIa and TF. Figure 5 depicts a pro®le of C a distance deviations obtained by optimally superimposing the individual domains/whole molecule of the chimeric FVIIa_TF after 810 ps (FVII (IXegf1) a-TF.810ps) onto that of wild-type FVIIa_TF after 510 ps (FVIIa-TF.510ps). In general, the deviations are similar to the B-factor pro®les, except for the N terminus of FVIIa. Dramatic differences occur in the joint Gla-EGF1 domain where deviations are calculated using the entire molecule as template ( Figure 5(b) ). This is consistent with the RMSD analysis ( Figure 3 ), which shows inter-domain mobility. Since the Gla and EGF1 domains are in contact with the fragments 2 and 3 of TF, it is likely that the mobile Gla-EGF1 domains causes larger C a distance difference in the interacting regions of TF (residues 91 to 210, Figure 5 (c)). In the catalytic domain, in addition to residues 170C to 175, 185 to 188 and 221A to 227 (see Table 1 for the full-length numbering as used in Figure 5 ), a-helix 164-169 and residues 142 to 150 (285 to 292) show elevated C a -distance deviations (calculated with the catalytic domain as the template). It is interesting that by mapping the surface loop regions ( Figure 5 ) with FX activation data, 12 we ®nd that the residues important for FX activation are also located in regions of large C a deviation, including residues 144 to 156, 184 to 187, and residues on Loop 2. The reduction of FX activation in the regions may be caused by affecting: (i) FX binding exosite residues E154, 26 R147 27 (this lab, data not shown); (ii) the S1 site and the N terminus insertion (D186), 13 and/or (iii) TF-catalysisenhancement-related residues, such as D186, L144 (see below) and F225. 13 Other surface loops in the catalytic domain are less likely involved in FX activation, except Loop 70-80 (210-220 in the fulllength numbering), which participates in calcium ion binding, and the catalytic cleft residue T99. 5 These FVII loops that are unrelated to FX activation are either distant from the presumed FX binding exosite and the catalytic cleft (V35-Q40 (172-176), K60A-N63 (197-203), Q110-V118 (250-258)) or are positioned at the end of the catalytic domain sequence and loosely connect (no H-bonds to the remain of the domain) to other part of the domain (residues E245 to V250 (394 to 399)). They are, therefore, less likely to be involved in small substrate hydrolysis and in TF-mediated enhancement of catalytic activity. However, these loops and some neighboring regions, (L32-Q40 (169-176), N63-R84 (203-224), and H109-Q110 (249-250)), are involved in an exosite for a peptide-inhibitor binding. 28 
Inter-domain/molecule H-bonds
The analysis of the simulation shows that the overall structure of FVII (IXegf1) a-TF.810ps remains similar to that of FVIIa-TF.510ps. FVII (IXegf1) a-TF.810ps retains all eight EGF2-catalytic domain H-bonds, and all three catalytic domain-TF-f1 H-bonds of the wild-type FVIIa-TF. However FVII (IXEgf1) a-TF.810ps lacks several important contacts with TF: positions 64 and 79 of the EGF1 domain (Q64-Q110t, two E56t-R79 H-bonds and E24t-R79), that are known to be important for FVIIa function. 17, 21 In a similar way, I16  153  L144  287  Q170  312  S185  333  V17  154  L145  288  Q170A  313  D186  334  G18  155  D146  289  S170B  314  G187  335  G19  156  R147  290  R170C  315  S188A  336  K20  157  G149  291  K170D  316  K188  337  H57  193  A150  292  V170E  317  D189  338  D102  242  T151  293  G170F  318  K192  341  R129B  271  A152  294  D170G  319  G193  342  T129C  272  L153  295  S170H  320  D194  343  L129D  273  E154  296  P170I  321  S195  344  A129E  274  M156  298  N175  322  Q217  366  F129F  275  V157  299  I176  323  A221A  369  V129G  276  M164  306  T177  324  T221 only two of six catalytic domain-TF-f2 H-bonds of FVIIa-TF are preserved in FVII (IXEgf1) a-TF.810ps. The H-bonds between the catalytic domain and the TF-f2 fragment in FVIIa-TF.510ps include T165-E91t, two R230-E91t bonds, E91t-E178, T94t-D167 and T96t-D167 ( Figure 6(a) ). In FVII (IXEgf1) a-TF.810 ps only one R230-E91t and T94t-D167 remain ( Figure 6 (b)), while T165:N-OE1:E91t, T165:OG1-OE1:E91t and Y94t:N-E1:Q166 are formed. These results con®rm that the EGF1-TF and catalytic domain-TF interfaces undergo substantial H-bond changes as a result of the chimera simulation.
Intra-catalytic domain H-bonds
FVII (IXEgf1) a-TF.810ps loses a number of intracatalytic domain H-bonds when compared to FVIIa-TF.510ps. These lost H-bonds may affect:
(i) the S1-binding site and the amino terminus insertion site of the catalytic domain. For instance, D189 is located at the bottom of S1 site. This residue is involved in 3 H-bonds with A221A and V17 ( Figure 6(c) ). The loss of these H-bonds leads to a deformed S1 site ( Figure 6(d) ). Also, disruption of the local H-bond network of D186 may be attributed to the increased mobility of the loop 2 ( Figure 6(d) ); (ii) the conformation of Loop 170s, including D170G-V170E and S170H-V170E Hbonds; (iii) the interactions of Loop 170s with Loop 1 and Loop 2. Disruption of these H-bonds S185-C170A, S170B-Q217 (Figure 6(c) and (d) ), and R230-M180 (Figure 6(a) ) is likely the cause of increased¯uctuation of these loops; ®nally; (iv) the integrity of Loop 140s and the interaction of Loop 140s with the active site ( Figure 7) . In chimeric FVIIa, D146 loses two H-bonds to K192. The sidechain of K192 shifts towards the active site. There- Surface Loops of FVIIa and Catalytic Activity fore, the main chain amide nitrogen atoms (particularly of G193), that determine the catalytic oxyanion hole, shift (Figure 7 ). This active site change, combined with the position shifting of D189 caused by S1-site deformation, may reasonably affect the catalytic activity of FVIIa.
Experimental Data by in vitro mutation
From the simulation analysis, it appears that the EGF1 domain substitution has an effect that is transmitted to the catalytic domain. Alteration of the catalytic domain/TF interface appears responsible. A major change appears to occur for Loop 170s. The effect resulting from the EGF1 substitution is initiated by perturbation of Loop 170s and is then passed on to the S1-substrate binding site and to Loop 140s, and ®nally to the residues critical for catalytic activity. To test this hypothesis, we generated four FVIIas with a single alanine substitution for each (L144A, R147A, D186A and K188A) that are located on the presumed TF-binding signal transmitting pathway; a multiple-mutation, MM3, a FVIIa that has mutations L144A, R147A and D186A; and a FVIIa with four residues (Q170, Q170A, S170B and R170C) deleted from Loop 170s (Loop 170s del ). results (Table 3 ). L144Aa and D186Aa rates (k cat /K m , catalytic ef®ciency) decreased by six-to sevenfold relative to wild-type FVIIa. The differences in catalytic ef®ciencies resulted largely from the decreases in k cat , of the mutants. It is also interesting to examine the effects that the mutants have on the enzymatic activity in the absence of TF. It allows us to examine if these residues are involved in the intrinsic catalytic activity, TF-enhanced catalytic activity or both.
The results (Table 3) show that catalytic ef®cien-cies for L144Aa and D186Aa were decreased by 0.4 to fourfold respectively without TF, indicating that L144 and especially D186 are involved in the catalytic activity of free FVIIa. FVIIa increases the catalytic activity of wild-type FVIIa toward S2288 by 36-fold, the mutant D186Aa by 23-fold and the mutant L144Aa by only eightfold, compared with the catalytic activities without TF. As a consequence, the decrease of catalytic activities and TF co-factor function for L144Aa and D186Aa lead to a six-to sevenfold lowering in catalytic ef®ciencies relative to wildtype. Mutation of both L144 and D186 leads to loss of almost all activity, even in the presence of TF. These data suggest that Loop 1 and Loop 140, in addition to being involved in the catalytic activity of FVIIa, are crucial for TF providing its catalytic activity-enhancing function (co-factor function). In other words, TF enhances FVIIa's catalytic activity, at least partially by affecting these loops.
Discussion
FVII/FVIIa is a multiple-domain molecule, with an extended-non-globular light chain at the N terminus. The light chain contains three small domains, Gla, EGF1 and EGF2, with a short fragment (residues 86L to 89L) that serves as a hinge between the two EGF-like domains and a short linear segment between the Gla and EGF1 domains. It is reasonable to expect that there exist interdomain motions. Because of the structural support from TF, however, domain-domain motions in the FVIIa-TF complex appear limited as shown in the RMSD calculation (Figure 2) for wild-type FVIIa-TF. Such domain-domain motion, even limited, between Gla and EGF1 in FVIIa may also be caused by the absence of membrane in the simulation system. Due to the disorder in some loop regions or to the enzyme's treatment with subtilisin to force crystallization, the initial coordinate set was missing residues 143L to 152L for FVIIa, and residues 1 to 5, 81 to 90, 159 to 162 and residues beyond 210 for TF. These missing surface-exposed regions do not appear to affect the structural integrity, since their locations are presumably orientated away from FVIIa-TF binding interfaces. This conclusion is con®rmed by the low RMSD values of the individual FVIIa domains and TF for the simulation structures.
The EGF1 domain itself was not as stable in the FVII (IXegf1) a-TF simulation as for the wild-type simulation. Larger domain-domain motions relative to FVIIa between Gla and EGF1 and even between EGF1 and EGF2 occurred in FVII (IXegf1) a-TF. The RMSD of TF was also affected. The evidence of the domain-domain motions is clearly shown in the C a distance plot ( Figure 5 ), in which the Gla and EGF1 domains (superimposed with whole molecule as the reference) demonstrate much larger differences in C a distance compared with the corresponding domains (superimposed with the individual domain as reference). These results indicate that substitution of the EGF1 domain has a signi®cant effect on the local conformation of FVIIa. This effect is transmitted to TF and the catalytic domain, causing several regions to have increased position¯uctuations and larger C a distance deviations between wild-type and chimeric FVIIa. These motions in Gla and EGF1 domains are consistent with the experimental TF binding af®nity, which decreases more than a hundred fold 21 for the chimeric FVIIa. Furthermore, since two C terminus residues (K165, K166) 29, 30 and several other residues of Loop 159-165 31 of TF are both near the Gla domain and have been shown to be involved in FX binding, the displacement of TF of the chimera ( Figure 5 ) may be reasonably considered to contribute to the decreased interaction rate of FVII (IXegf1) a-TF with FX. The EGF2 domain of FVIIa has a hydrophobic interaction with TF near the catalytic domain-TF interface. This interaction involves side-chains of Q88L, N93L, E94L, V92L, F50t, Y51t and K41t. The largely hydrophobic area interacts with Loop 121-124L through residues N95L, C98L, E99L and S126L. The latter residue forms two H-bonds with loop residue D123L, which are essential for Loop 121-124L stability. In FVII (IXegf1) a-TF, however, F50t and Y51t of TF are displaced in such a manner that the hydrophobic interaction in this region is diminished. Also the two H-bonds of S126L to D123L are lost, resulting in increased¯uctuation of Loop 121-124L (Figure 4) . Furthermore, because of the loss of the H-bond N93L-L89L for FVII (IXegf1) a-TF, the Q88L-K85L bond, which is responsible for stability of the hinge between EGF1 and EGF2, was also lost, resulting in higher B-factors for residues 85L to 89L of the chimera relative to the FVIIa-TF simulation. These changes in the EGF2 domain may contribute to the decreased TF-binding af®-nity of the chimeric FVIIa. No signi®cant rotation of the EGF2 domain relative to the catalytic domain occurred in the chimeric FVIIa simulation. The observed EGF2 domain rotation of free FVIIa 16 relative to the protease domain of TF-bound FVIIa could be caused by the disordered EGF1 domain of the Gla-domainless FVIIa.
21
The surface loops of FVIIa-TF and its chimera have substantial¯uctuations (Figure 4) . For the chimera complex the B-factors at residues 170C to 175, 185 to 188 and 221A to 224 are roughly twice those of FVIIa-TF, indicating that these areas are most susceptible to the alterations in the catalytic domain-TF interface. The position shifting of these loops 15 relative to the FVIIa-TF complex and disordering of Loop 170s 16 are observed in free FVIIa. These three loops are spatially adjacent and connected via several Hbond interactions (Figure 6(c) ). It is likely that the greater¯uctuations are caused by disruption of the catalytic domain-TF interface, 15 resulting in a breakdown of the local H-bond network among these loops (Figure 6(d) ). This structural difference may account for the decreased activity of FVIIa in the absence of TF.
D186 is one of critical residues for maintaining the integrity of Loop 1 conformation. In wild-type FVIIa, residue D186 is involved in three H-bonds (Figure 6(c) ). In FVII (IXegf1) a-TF.810ps, only S188A-D186 was formed (Figure 6(d) ). Due to the loss of the S185-Q170A and Q217-S170B H-bonds and G223-S185 H-bond formation, Loop 1 refolded. It is reasonable to conclude that impairment of the local H-bond network involving Loop 1 leads to deformation of the S1-binding site. This speculation is supported by in vitro mutagenesis of D186 in this study (Tables 2 and 3 ) and by the work of Petrovan and Ruf. 13 Mutant D186Aa is defective in protection of the N-terminal terminus from the chemical modi®cation in the presence of TF. 13 The mutation K188A, however, showed no effect and even a small increase in activity, probably because the mutant retained signi®cant D186 H-bond interactions. The importance of Loop 2 has also been observed. 13 F225, a partially buried residue and located in the end of Loop 2, has been suggested as an independent linkage to transmit the activation signal from the protease-TF interface to the active site. 13 Consistent with that study, the position of F225 was signi®cantly moved from wild-type ( Figure 5 ), indicating that both presumed mechanisms 13 (enhancing FVIIa's catalytic activity with/without affecting the N terminus insertion respectively) could be in response to the substitution of the EGF1 domain on the catalytic activity of FVIIa. E154, which is located in the macromolecule binding exosite of the catalytic domain, may also be involved. 26 The H-bonds D189-V17 and V17-D189 of Loop 1 provide support for the catalytic domain N terminus insertion (Figure 6(c) ), based on their positions adjacent to the N terminus insertion residue I16. The H-bond K20-V157 may also be involved. The N terminus insertion is thought to be associated with the mechanism of Sp activation 32 and stabilized by TF-binding FVIIa. 13, [33] [34] [35] [36] Active site occupation by inhibitor has also been suggested to provide stabilization for the N terminus insertion. 16 The N terminus insertion of FVII (IXegf1) a might be expected to have a signi®cant shift in position, due to the loss of the H-bonds K20-V157, V17-D189 and D189-V17. However, the morphology of the insertion region shows little change in the chimera. Therefore, other factors must play key roles in maintaining the integrity of the N terminus insertion. In addition to Loop 1, the insertion region consists of Loop 140s and residues G18 and V17. M156 is also near the insertion in this hydrophobic region (Figure 1 ). This residue is considered to be a determinant for the zymogen-like properties of FVIIa. 36 The residues G142, Q143, L144 and L145 might be important for maintaining the stability of the N terminus insertion, since they are either fully or partially buried and nearby the insertion. In general, the structure surrounding the N terminus insertion remains similar between wild-type and chimeric molecules. The C a -distances of residues 144 to 150 of Loop 140s between the chimera and the wild-type FVIIa show some deviations ( Figure 5 ), which appear to be caused by loss of the H-bonds K20-V157, V17-D189 and D189-V17. Although the motion of Loop 140s ( Figure 5 ) of the chimera results in only small alteration of the I16-D194 interaction, an intra-loop H-bond Q143-D146 and two H-bonds of D146 to K192 are lost ( Figure 7) . Disruption of the H-bond interaction of K192 with Loop 140s may affect the formation of the oxyanion hole of the active site, since K192 is adjacent to G193, which provides stabilization of the oxyanion hole. K192 has been shown to play a role in FX activation 12, 26 and chromogenic-substrate hydrolysis. 26 The importance of Loop 140s for FVIIa catalytic activity has been demonstrated in another X-ray crystal study 28 of FVIIa in complex with a peptide Surface Loops of FVIIa and Catalytic Activity inhibitor. In the FVIIa-inhibitor complex, Loop 140s shifts so as to break a H-bond between the amide nitrogen of Q143 and the carbonyl oxygen of K192. This results in an inhibitory effect on the catalytic activity towards a chromogenic substrate and FX activation. We and others 12, 26 have also shown that structural perturbation caused by mutation of L144 decreases FVIIa amidolytic activity or FX activation. L144 is part of a local hydrophobic patch. A change in this patch decreases the catalytic activity possibly by affecting the stability of the I16-D194 salt bridge at the N terminus insertion and/or H-bond interaction of Loop 140s with K192. Since both Loop 1 and Loop 140s are located near the N terminus insertion position, the reduction by a factor of 10 2 of FVIIa's amidolytic activity from mutation of both L144 and D186 (mutant MM3) suggests that Loop 1 and Loop 140s are crucial for the stability of N terminus insertion. Although L144 and D186 are not active site residues, their mutants were unable to fully transfer TF's catalytic activity-enhancing effect to the active site (78 % and 35 % reduction for L144Aa and D186Aa, respectively, Table 3 ). The implication is that L144 and D186 not only participate in supporting the catalytic function of FVIIa, but also are required for co-factor-induced enhancement of catalytic activity.
When the four residues Q170, Q170A, S170B and R170C were deleted, the two H-bonds (S185-Q170A and S170B-Q217) that connect to Loop 1 and Loop 2, respectively, were lost. This deletion may mimic the effect of the EGF1 domain substitution on the catalytic domain in that the missing H-bonds may result in Loop 1 and Loop 2 shifting, that in turn leads to S1 site alteration. We ®nd that partial deletion of Loop 170s decreases the amidolytic activity of FVIIa by two-to threefold with or without TF. However, mutant Loop170s del a showed a signi®cant cofactor-mediated enhancement of the catalytic ef®ciency for chromogenic substrate (43-fold for the deletion mutant, 36-fold for wild-type, Table 3 ). Unlike FVII (IXegf1) a, 21 Loop170s del a of FVIIa has a normal TF binding af®-nity (Table 2) ; the amidolytic activity is affected in the absence of TF; and the deletion has no effect on FX activation (data not shown). The evidence indicates that Loop170s del a reacts differently from FVII (IXegf1) a and that interruption of Loop 170s, even with a normal catalytic domain-TF interface, leads to modi®ed catalytic activity. Loop170s del a appears not to affect the cofactor-induced stability of Loop1, Loop 2 and the N-terminal insertion. The lack of an effect for Loop170s del a may be because that the H-bond de®ciency in the local area of Loop170s del a is overcome by the second allosteric network effect, involving residue F225, 13 or that Loop 170s of Loop170s del a may generate new Hbond connections with Loop 1 and Loop 2, that maintain stability of the local structure.
Concluding comments
Several X-ray crystallography studies have been performed to study the mechanism by which TF enhances FVIIa's catalytic activity. 5, 15, 16, 37 Because of the crystal packing and the inhibitor occupation in the active site, it is dif®cult to observe inhibitorfree FVIIa and inhibitor-free TF-complexed FVIIa. Our simulations employ FVIIa/FVII (IXegf1) a-TF complexes without inhibitor to investigate the conformational changes that result from the EGF1 domain substitution and thereby modify the TFmediated enhancement of FVIIa's catalytic activity. We ®nd that, in addition to signi®cant interdomain displacements that occur in the light chain of FVIIa, the most¯exible regions in the catalytic domain of FVII IXegf1 are those of Loop 1, Loop 2 and Loop 170s. The N terminus insertion has not been appreciably affected by these more¯exible loops, although Loop 140s results in a slight alteration of the active site. This work demonstrates a complementary approach (simulation) for studying the mechanism of EGF1 domain substitution on the catalytic activity of FVIIa. Our combined simulations and experiments suggest that the stability and appropriate positioning of the light chain is important for full cofactor activity. Loop 1, Loop 2, Loop 140s and Loop 170s in the catalytic domain of FVIIa transmit the TF-mediated effect through the catalytic domain-TF interface. Alteration of these regions appears to cause deformation of the S1 substrate binding site and to destabilize the N terminus insertion, with a concomitant effect on the active site. Our model thus provides new insight into the mechanism by which TF enhances FVIIa's catalytic activity.
Computational Procedure Model constructions and simulation protocol
The initial structure of FVIIa-TF (residues 1 to 142, 153 to 406 of FVIIa and residues 6 to 80, 91 to 158 and 163 to 210 of TF) for modeling was obtained from entry 1dan in RCSB Protein Data Base (PDB). Because of the subtilisin treatment (residues <6, residues >210, and the cleavage loop 85-89) and disorder of several loops (residues 135 to 138, 158 to 164, and 181 to 183), the coordinates of TF for residues 1 to 5, 81 to 90, 159 to 162 and after 210 were missing, resulting in the extracellular three fragments, fragment 1(TF-f1, residues 6 to 80), fragment 2 (TF-f2, 91-158) and fragment 3 (TFf3, 163-210). TF-f1 and TF-f3 are located within the N terminus and C terminus domains, respectively, while TF-f2 consists of sections of the C and N domains. The simulation was performed as described by Perera et al. 25, 38 All nine Ca 2 coordinates assigned in the X-ray crystal form, including 239 crystallographic water molecules, were preserved in the initial structure. Necessary hydrogen atoms and counter ions were added to the X-ray crystallographic structure, followed by energy minimization of the side-chains (500 steepest descent plus 10,000 conjugate gradient steps). For construction of the FVIIa chimera with FIX's EGF1 domain (FVII (IXegf1) a), 12 residues in FVIIa, which differ in FVII and FIX EGF1 domains, were sequentially mutated, one at a time, to FIX's residues, with sequential energy minimization of the sidechains (500 steepest descent and followed by 10,000 conjugated gradient steps) for each mutation. After all mutations were completed, the energy minimization of the side-chains, counterions, calcium and crystal water was carried out for 10,000 steps, followed by energy minimization of the entire system.
The proteins, along with the crystallographic water molecules, the calcium ions and the counter ions, were then solvated in a box of water molecules, for which the boundaries were 12.5 A Ê away from any protein atom. Water molecules were excluded if any atom was less than 2.0 A Ê from the proteins. The simulation box contained 587 residues, 25,195 water molecules for FVIIa-TF (25, 432 for FVII IXegf1 a-TF), 9 calcium ions and counter ions Cl À (seven for FVIIa-TF, four for FVII IXegf1 a-TF). The counter ions ensure electrical neutrality. The added water molecules were then energy minimized at constant volume. All of the water molecules were then subjected to energy minimization. Finally, the entire system was energy minimized. The system was subsequently subjected to a slow heat-up procedure to bring the temperature of the system to 325 K. After 25 ps of a constant volume/ constant temperature simulation, the system was brought back to 300 K, followed by a constant T/V simulation for 50 ps. In the ®nal, major step, a constant T/P protocol was adopted to simulate 510 ps of dynamics for wild-type FVIIa-TF and 810 ps for FVII (IXegf1) a-TF (the coordinates are available from jjin@unc.edu).
Here, we used the AMBER version 5.0 39 in conjunction with the particle mesh Ewald method 40 to accommodate long-range interaction (both Lennard-Jones and electrostatic interactions) in all solution simulations. The time step was 1 fs, with the non-bonded interactions updated at every step. The translational and rotational motions of the center of mass were removed at the beginning and regular 2.5-ps intervals. All covalent bonds involving hydrogens were constrained by a modi®ed form of SHAKE. 41 
Experimental Materials and Methods
Materials
The recombinant TF apoprotein (residues 1 to 243) was a generous gift from Dr Gordon Vehar (Genentech, Inc., South San Francisco, CA). Chromogenic substrate S-2288 (H-D-isoleucyl-L-prolyl-L-arginine-p-nitroanilinedihydrochloride: H-D-Ile-Pro-Arg-pNA Á2HCl) was purchased from DiaPhama Group, Inc. (West Chester, OH). The E.I.A/R.I.A plates for amidolytic assays were purchased from Costar Corporation (Cambridge, MA). Oligonucleotides were synthesized by GIBCO BRL Life Technologies (Grand Island, New York). Restriction enzymes, ligase and DNA polymerase were purchased from New England Biolabs (Beverly, MA). Vitamin K was from Abbott Laboratories (North Chicago, IL). Insulin-transferrin-sodium selenite tissue culture supplement was from Boehringer Mannheim (Indianapolis, IN). Dulbecco's Modi®ed Eagle Medium (D-MEM/F-12) was from GIBCO BRL Life Technologies (Grand Island, New York).
Site-directed mutagenesis
A human FVII cDNA construct was used as the starting material to create mutant FVII's. A megaprimer PCR was performed to generate constructs with mutations. 42, 43 The PCR consisted of two steps which were as follows: the ®rst step was to generate a megaprimer (200 bp < megaprimer < 500 bp) by using a pair of oligonucleotide primers, one of which contained the mutation desired; the PCR product from the ®rst round PCR was isolated from a agarose gel; after puri®cation, the megaprimer was used to perform the second round of PCR with another oligonucleotide primer, that was complementary to the opposite strand DNA relative to the ®rst primer. The expected mutations and full sequence of the constructs were con®rmed by sequencing performed by the UNC-CH Sequencing Facilities.
Expression, purification, activation and characterization of proteins
Wild-type and mutant FVIIs were expressed, puri®ed and activated essentially as described by Jin et al.
21
Amidolytic activity assay and kinetics analysis
The assays were performed as described by Jin et al. 
